Lars Prestegarden

1.9k total citations
13 papers, 1.0k citations indexed

About

Lars Prestegarden is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Lars Prestegarden has authored 13 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 5 papers in Oncology and 4 papers in Genetics. Recurrent topics in Lars Prestegarden's work include Autophagy in Disease and Therapy (4 papers), Glioma Diagnosis and Treatment (4 papers) and Cancer Cells and Metastasis (3 papers). Lars Prestegarden is often cited by papers focused on Autophagy in Disease and Therapy (4 papers), Glioma Diagnosis and Treatment (4 papers) and Cancer Cells and Metastasis (3 papers). Lars Prestegarden collaborates with scholars based in Norway, Luxembourg and China. Lars Prestegarden's co-authors include Rolf Bjerkvig, Jian Wang, Per Øyvind Enger, Frits Thorsen, Per Øystein Sakariassen, Agnete Svendsen, Gro Vatne Røsland, Anders Molven, Linda Stuhr and Heike Immervoll and has published in prestigious journals such as Cancer Research, Annals of Oncology and International Journal of Cancer.

In The Last Decade

Lars Prestegarden

13 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lars Prestegarden Norway 11 536 444 322 308 162 13 1.0k
Sabine Spiegl‐Kreinecker Austria 22 866 1.6× 288 0.6× 265 0.8× 348 1.1× 171 1.1× 45 1.6k
Monica Gatti Italy 20 561 1.0× 467 1.1× 217 0.7× 194 0.6× 178 1.1× 26 1.1k
Lucas Santana‐Santos United States 12 641 1.2× 266 0.6× 402 1.2× 252 0.8× 90 0.6× 30 1.3k
Arabel Vollmann‐Zwerenz Germany 15 459 0.9× 240 0.5× 231 0.7× 182 0.6× 48 0.3× 24 881
Patrick T. Grogan United States 18 740 1.4× 361 0.8× 309 1.0× 604 2.0× 61 0.4× 33 1.4k
Keita Shibuya Japan 12 592 1.1× 313 0.7× 288 0.9× 149 0.5× 61 0.4× 14 892
Nancy De Nève Belgium 17 490 0.9× 211 0.5× 216 0.7× 142 0.5× 58 0.4× 31 961
Eiji Iwado United States 12 739 1.4× 377 0.8× 203 0.6× 118 0.4× 435 2.7× 14 1.2k
Georg Gdynia Germany 14 510 1.0× 224 0.5× 206 0.6× 132 0.4× 97 0.6× 22 860
Amparo Wolf Canada 10 913 1.7× 172 0.4× 683 2.1× 288 0.9× 91 0.6× 11 1.4k

Countries citing papers authored by Lars Prestegarden

Since Specialization
Citations

This map shows the geographic impact of Lars Prestegarden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Prestegarden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Prestegarden more than expected).

Fields of papers citing papers by Lars Prestegarden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lars Prestegarden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Prestegarden. The network helps show where Lars Prestegarden may publish in the future.

Co-authorship network of co-authors of Lars Prestegarden

This figure shows the co-authorship network connecting the top 25 collaborators of Lars Prestegarden. A scholar is included among the top collaborators of Lars Prestegarden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lars Prestegarden. Lars Prestegarden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Janji, Bassam, Muhammad Zaeem Noman, Md. Jakir Hossain, et al.. (2023). 2308P CyPep-1 reprograms the tumor microenvironment and enhances the efficacy of immune checkpoint inhibitors. Annals of Oncology. 34. S1180–S1180. 1 indexed citations
2.
Johannessen, Tor‐Christian, Md Mahdi Hasan‐Olive, Oxana V. Denisova, et al.. (2018). Thioridazine inhibits autophagy and sensitizes glioblastoma cells to temozolomide. International Journal of Cancer. 144(7). 1735–1745. 61 indexed citations
3.
Wang, Jiwei, Qichao Qi, Wenjing Zhou, et al.. (2018). Inhibition of glioma growth by flavokawain B is mediated through endoplasmic reticulum stress induced autophagy. Autophagy. 14(11). 2007–2022. 119 indexed citations
4.
Zhang, Xin, Ran Xu, Chao Zhang, et al.. (2017). Trifluoperazine, a novel autophagy inhibitor, increases radiosensitivity in glioblastoma by impairing homologous recombination. Journal of Experimental & Clinical Cancer Research. 36(1). 118–118. 51 indexed citations
5.
Wang, Jiwei, Qichao Qi, Zichao Feng, et al.. (2016). Berberine induces autophagy in glioblastoma by targeting the AMPK/mTOR/ULK1-pathway. Oncotarget. 7(41). 66944–66958. 124 indexed citations
6.
Sundstrøm, Terje, Jobin K. Varughese, Lars Prestegarden, et al.. (2015). BMET-34DRUG REPURPOSING DISCOVERS BETA-SITOSTEROL AS AN EFFECTIVE THERAPEUTIC AGENT AGAINST MELANOMA BRAIN METASTASES IN VIVO. Neuro-Oncology. 17(suppl 5). v52.3–v52. 1 indexed citations
7.
Tenstad, Olav, Anne Baumann, Aurora Martı́nez, et al.. (2014). Identification of a novel lytic peptide for the treatment of solid tumours. Genes & Cancer. 5(5-6). 186–200. 18 indexed citations
8.
Johannessen, Tor‐Christian, Lars Prestegarden, Amra Grudic, et al.. (2012). The DNA repair protein ALKBH2 mediates temozolomide resistance in human glioblastoma cells. Neuro-Oncology. 15(3). 269–278. 83 indexed citations
9.
Prestegarden, Lars, Agnete Svendsen, Jian Wang, et al.. (2010). Glioma Cell Populations Grouped by Different Cell Type Markers Drive Brain Tumor Growth. Cancer Research. 70(11). 4274–4279. 69 indexed citations
10.
Prestegarden, Lars & Per Øyvind Enger. (2010). Cancer Stem Cells in the Central Nervous System – A Critical Review. Cancer Research. 70(21). 8255–8258. 28 indexed citations
11.
Wang, Jian, Per Øystein Sakariassen, Oleg Tsinkalovsky, et al.. (2007). CD133 negative glioma cells form tumors in nude rats and give rise to CD133 positive cells. International Journal of Cancer. 122(4). 761–768. 423 indexed citations
12.
Skaftnesmo, Kai Ove, Lars Prestegarden, David Micklem, & James B. Lorens. (2007). MicroRNAs in Tumorigenesis. Current Pharmaceutical Biotechnology. 8(6). 320–325. 44 indexed citations
13.
Sundlisæter, Eirik, Jian Wang, Per Øystein Sakariassen, et al.. (2006). Primary glioma spheroids maintain tumourogenicity and essential phenotypic traits after cryopreservation. Neuropathology and Applied Neurobiology. 32(4). 419–427. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sabine Spiegl‐Kreinecker Breakdown of academic impact, for papers by Monica Gatti Breakdown of academic impact, for papers by Lucas Santana‐Santos Breakdown of academic impact, for papers by Arabel Vollmann‐Zwerenz Breakdown of academic impact, for papers by Patrick T. Grogan Breakdown of academic impact, for papers by Keita Shibuya Breakdown of academic impact, for papers by Nancy De Nève Breakdown of academic impact, for papers by Eiji Iwado Breakdown of academic impact, for papers by Georg Gdynia Breakdown of academic impact, for papers by Amparo Wolf
Rankless by CCL
2026